USA Rare Earth’s $2.8B Bet to Break China’s Rare Earth Hold
USA Rare Earth’s $2.8B acquisition of Brazil’s Serra Verde marks a turning point in the West’s push to secure critical mineral supply chains outside China.
USA Rare Earth’s $2.8B acquisition of Brazil’s Serra Verde marks a turning point in the West’s push to secure critical mineral supply chains outside China.
With 400+ companies reporting this week and EPS estimates rising again, Q1 2026’s peak earnings week is a key test for the market’s record-breaking rally.
Intuitive Surgical reports Q1 2026 earnings April 21 with its stock down 20% YTD. Here’s what analysts are watching — from da Vinci 5 adoption to the China challenge.
UnitedHealth reports Q1 2026 earnings April 22. Medical loss ratios, Medicaid risk, Optum growth — and what it means for healthcare stocks.
The IMF says runaway U.S. debt is eliminating the traditional safety premium on Treasury bonds — and the implications stretch far beyond fixed income.
QXO, led by serial dealmaker Brad Jacobs, agreed to acquire building products leader TopBuild for $17 billion—one of 2026’s largest M&A transactions.
Google is in talks with Marvell to build next-gen AI inference chips. Here’s what the custom silicon arms race means for MRVL, NVDA, and the broader semiconductor sector.
U.S. utilities are planning $1.4 trillion in capex to power AI data centers — and financing it means a $770B bond issuance wave that will reshape investment-grade credit markets.
Enterprise software is rebounding in 2026, but gains are selective. RingCentral and Oracle reveal what separates the winners from the laggards.
Sticky 3.3% inflation, oil price shocks, and a Fed frozen on rate cuts are reviving stagflation fears not seen since the 1970s. Here’s what capital markets are signaling.